Ana Paula Braga Lima

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Histone Deacetylase

Top Venues

Molecules (Basel, Switzerland)

Natural product research

Cancer investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Isadora Oliveira Ansaloni Pereira, Glenda Nicioli da Silva, Tamires Cunha Almeida, Ana Paula Braga Lima, André Luiz Ventura Sávio, Katia Ramos Moreira Leite, Daisy Maria Fávero Salvadori
LncRNA JHDM1D-AS1 Is a Key Biomarker for Progression and Modulation of Gemcitabine Sensitivity in Bladder Cancer Cells. Molecules (Basel, Switzerland) 28 (5) (2023)
Isadora Oliveira Ansaloni Pereira, Glenda Nicioli da Silva, Tamires Cunha Almeida, Ana Paula Braga Lima, André Luiz Ventura Sávio, Katia Ramos Moreira Leite, Daisy Maria Fávero Salvadori
LncRNA JHDM1D-AS1 Is a Key Biomarker for Progression and Modulation of Gemcitabine Sensitivity in Bladder Cancer Cells. Molecules (Basel, Switzerland) 28 (5) (2023)
Isadora Oliveira Ansaloni Pereira, Glenda Nicioli da Silva, Tamires Cunha Almeida, Ana Paula Braga Lima, André Luiz Ventura Sávio, Katia Ramos Moreira Leite, Daisy Maria Fávero Salvadori
LncRNA JHDM1D-AS1 Is a Key Biomarker for Progression and Modulation of Gemcitabine Sensitivity in Bladder Cancer Cells. Molecules (Basel, Switzerland) 28 (5) (2023)
Ana Paula Braga Lima, André Sacramento Melo, Gabriel Monteze Ferreira, Glenda Nicioli da Silva
Chrysin inhibits the cell viability, induces apoptosis and modulates expression of genes related to epigenetic events in bladder cancer cells. Natural product research (2022)
Tamires Cunha Almeida, André Sacramento Melo, Ana Paula Braga Lima, Renata Tupinambá Branquinho, Glenda Nicioli da Silva
Resveratrol induces the production of reactive oxygen species, interferes with the cell cycle, and inhibits the cell migration of bladder tumour cells with different TP53 status. Natural product research (2022)
Ana Paula Braga Lima, Glenda Nicioli da Silva
Long Non-Coding RNA and Chemoresistance in Bladder Cancer - A Mini Review. Cancer investigation (2022)